Patent: 5,541,293
✉ Email this page to a colleague
Summary for Patent: 5,541,293
| Title: | Consensus human leukocyte interferon |
| Abstract: | Disclosed are analogs of human leukocyte interferon which predominantly include those amino acid residues which are common to all naturally-occurring human leukocyte interferon subtype amino acid sequences and which include, at one or more of those positions where there is no amino acid common to all subtypes, an amino acid which predominantly occurs at that position and in no event include any amino acid residue which is not extant in that position in at least one naturally-occurring subtype. |
| Inventor(s): | Stabinsky; Yitzhak (Boulder, CO) |
| Assignee: | Amgen Inc. (Thousand Oaks, CA) |
| Application Number: | 07/472,328 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,541,293
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | 10/06/1997 | ⤷ Try a Trial | 2002-05-06 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,541,293
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 8304053 | ⤷ Try a Trial |
| United States of America | RE39821 | ⤷ Try a Trial |
| United States of America | 6936695 | ⤷ Try a Trial |
| United States of America | 6936694 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
